As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…
HOME > ACADEMIA
ACADEMIA
- Japan Esophageal Society to Recommend 5-FU + Cisplatin as 1st-Line Therapy for Esophageal Cancer in New Guidelines
July 7, 2016
- MHLW Working Group Drafting Guidelines for Development of Cell Therapies for Cerebral Infarction
July 4, 2016
- Accelerate Investigator-Initiated Trials to Promote Academia-Led Drug Discovery: New NCGM Research Center Chief
July 1, 2016
- 865,238 People Diagnosed with Cancer in 2012: NCC
June 30, 2016
- MHLW Study Group Aims to Formulate Guidelines for Treatment of Skeletal Dysplasias in FY2017
June 29, 2016
- Nexium, Takecab Added to Standard Treatments for 1st Eradication of H. Pylori: JSHR Guidelines
June 28, 2016
- PD-1’s “Actual Physiology Remains Unclear”: Discoverer of PD-1
June 21, 2016
- No Increased Mortality Risks Seen in Japanese AD Patients on Antipsychotics: Study
June 17, 2016
- Victoza 1st GLP-1 Agent to Thwart Cardiovascular Events; Will It Catch on?
June 15, 2016
- Academic Societies Drafting Guidelines for Clinically Evaluating Efficacy of Drugs for AMR Infectious Diseases
June 15, 2016
- As Spate of Melanoma Drugs Debut, Physicians Still Exploring Best Drug Choices, Combos
June 14, 2016
- Gilead’s 2 Hep C Treatments Highly Effective in Actual Clinical Practice: Multicenter Studies Results
May 24, 2016
- Diabetes Society Calls for Careful Administration of SGLT-2 Inhibitors to Geriatric Syndrome Patients, Aged 75 or Over
May 19, 2016
- MHLW Study Group Drafting Guidelines for Assessing Cost-Effectiveness of Vaccines Proposed for Inclusion in Public Vaccination Programs
May 16, 2016
- Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
May 9, 2016
- At Least 20% of Patients Taking Xeljanz against Guidelines: Interim Analysis of PMS
April 26, 2016
- AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
April 21, 2016
- 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
April 20, 2016
- Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer
March 23, 2016
- It’s Time to Discuss Restart of HPV Vaccine Promotion, Panel Chief Says as Personal View
March 16, 2016
ページ
Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…